Tat’yAna Alekseevna Shustova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tat’yAna Alekseevna Shustova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Mariya Petrovna Topuzova
Almazov National Medical Research Center
9 shared publications - Tatyana M. Alekseeva
V.A. Almazov National Medical Research Centre, Ministry of Health of Russia
9 shared publications - Ivan Konstantinovich Ternovykh
FSBI Almazov National Medical Research Center of the Ministry of Health of the Russian Federation, St. Petersburg, Russia
7 shared publications - Maria L. Pospelova
Federal State Budgetary Institution “V. A. Almazov National Medical Research Centre” of the Ministry of Health of the Russian Federation
2 shared publications - Nataliya Evgen’eVna Dudnikova
Almazov National Medical Research Centre
2 shared publications - P. A. Grigorieva
Almazov National Medical Research Center
2 shared publications
Latest Publications
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , 133-137
Results of the scientific and practical conference with international participation «Neurology of the XXI Century: Current Issues, Achievements and Innovations». March 26—27, 2026, St. Petersburg
This article presents the findings from the fifth scientific and practical conference with international participation entitled «Neurology of the XXI Century: Current Issues, Achievements and Innovations,» held on March 26—27, 2026, in St. Petersburg. The scientific program included plenary sessions, sectional reports, master classes, educational events, and clinical cases presented by participants from both Russia and abroad. The conference attracted over 1.000 specialists. Key topics discussed included vascular pathology of the brain, neurodegenerative diseases, immune-mediated neuromuscular disorders, multiple sclerosis, epilepsy, neuroinfections, pain syndromes, and medical rehabilitation. Special emphasis was placed on the importance of interdisciplinary approaches and personalized medicine. The conference not only highlighted a high standard of scientific and educational engagement but also fostered professional exchange of experiences and pinpointed promising directions for advancing neurology. The next conference is scheduled for spring 2027.
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , 133-137
Results of the scientific and practical conference with international participation «Neurology of the XXI Century: Current Issues, Achievements and Innovations». March 26—27, 2026, St. Petersburg
This article presents the findings from the fifth scientific and practical conference with international participation entitled «Neurology of the XXI Century: Current Issues, Achievements and Innovations,» held on March 26—27, 2026, in St. Petersburg. The scientific program included plenary sessions, sectional reports, master classes, educational events, and clinical cases presented by participants from both Russia and abroad. The conference attracted over 1.000 specialists. Key topics discussed included vascular pathology of the brain, neurodegenerative diseases, immune-mediated neuromuscular disorders, multiple sclerosis, epilepsy, neuroinfections, pain syndromes, and medical rehabilitation. Special emphasis was placed on the importance of interdisciplinary approaches and personalized medicine. The conference not only highlighted a high standard of scientific and educational engagement but also fostered professional exchange of experiences and pinpointed promising directions for advancing neurology. The next conference is scheduled for spring 2027.
- 30 April 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 4,p. 629-639
Structural characteristics of night sleep and dynamics of impaired functions recovery in patients after ischemic stroke
In addition to immediate focal neurological impairments, patients often experience significant mood swings, fatigue, and sleep disturbances during recovery from ischemic stroke. If left unnoticed and not promptly addressed, these conditions can negatively impact neuroplasticity, which is essential for restoring impaired functions. The purpose of this study was to evaluate the impact of disrupted nocturnal sleep patterns on the dynamics of motor, cognitive, and affective impairments in patients who have suffered ischemic stroke. The study included 115 patients after ischemic stroke. In patients in the acute period of ischemic stroke, the highest apnea-hypopnea index was detected (27.00 [14.55; 38.80] episodes/hour, p<0.05), while insomnia disorders predominated in the early and late recovery periods, expressed in a decrease in sleep efficiency to 46-50% (with the norm of 70%) and an increase in the time of falling asleep. A higher apnea-hypopnea index was associated with a slower regression of anxiety manifestations (ρ=-0.356, p=0.008). At the same time, higher sleep efficiency and the presence of deep slow sleep were associated with better recovery of mobility and a decrease in the level of anxiety in patients, respectively. This study demonstrates that the nature of sleep disorders in patients after ischemic stroke regularly changes depending on the period of the disease. This highlights the importance of targeted sleep assessment at all stages of rehabilitation and points to potential therapeutic targets for optimizing the recovery of neurological and emotional functions.
- 30 April 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 4,p. 629-639
Structural characteristics of night sleep and dynamics of impaired functions recovery in patients after ischemic stroke
In addition to immediate focal neurological impairments, patients often experience significant mood swings, fatigue, and sleep disturbances during recovery from ischemic stroke. If left unnoticed and not promptly addressed, these conditions can negatively impact neuroplasticity, which is essential for restoring impaired functions. The purpose of this study was to evaluate the impact of disrupted nocturnal sleep patterns on the dynamics of motor, cognitive, and affective impairments in patients who have suffered ischemic stroke. The study included 115 patients after ischemic stroke. In patients in the acute period of ischemic stroke, the highest apnea-hypopnea index was detected (27.00 [14.55; 38.80] episodes/hour, p<0.05), while insomnia disorders predominated in the early and late recovery periods, expressed in a decrease in sleep efficiency to 46-50% (with the norm of 70%) and an increase in the time of falling asleep. A higher apnea-hypopnea index was associated with a slower regression of anxiety manifestations (ρ=-0.356, p=0.008). At the same time, higher sleep efficiency and the presence of deep slow sleep were associated with better recovery of mobility and a decrease in the level of anxiety in patients, respectively. This study demonstrates that the nature of sleep disorders in patients after ischemic stroke regularly changes depending on the period of the disease. This highlights the importance of targeted sleep assessment at all stages of rehabilitation and points to potential therapeutic targets for optimizing the recovery of neurological and emotional functions.
- Open Access
- 2 May 2025
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 17 (1) , 37-50
Hypersomnolence and fatigue in patients in the acute period of ischemic stroke
INTRODUCTION. Fatigue after stroke has attracted research attention, but there is still insufficient evidence to estimate its prevalence and identify factors for its variability. As this condition has multiple implications for stroke survivors and the lives of their families, there is a need to find evidence regarding the causal relationship of fatigue with other post-stroke conditions.AIM. To evaluate the dependence of the degree of hypersomnolence and fatigue on the severity, volume, localisation of the lesion focus and subtype of ischemic stroke (IS) according to the TOAST classification and to study the influence of neurological deficit on the severity of fatigue in patients in the acute period of IS.MATERIALS AND METHODS. 80 patients in the acute period of IS were included in the study. During the examination, the subtype, basin and volume of the ischaemic focus were recorded. Fatigue was assessed using FIS and FSS scales, sleepiness was assessed using a sleep diary, ESS and KSS scales, and stroke severity was assessed using NIHSS, Rankin, Bartel, and Rivermead scales. Statistical data processing was performed using StatPlus Mac software package (USA). The significance level for statistical hypothesis testing was taken as p 0.05.RESULTS. Hypersomnolence was detected in 37 patients, predominantly with unspecified subtype of IS, without dependence on the volume of the focus and severity of IS. To a greater extent, drowsiness was demonstrated in patients with right-sided localisation of the ischemia focus. Fatigue was observed in 17 patients regardless of the subtype of IS, localisation and volume of IS. The level of fatigue was higher in patients with greater neurological deficit and less mobility. No association of fatigue with the presence or absence of hypersomnolence was found.CONCLUSION. The established correlation of hypersomnolence with the subtype of IS, affected hemisphere can serve as a reference point for predicting the outcomes of IS and developing individual patient treatment tactics. The revealed regularities, the discrepancy of data on the dependence of fatigue and sleepiness severity on the subtype of IS and localisation of the lesion focus allow us to assert the possibility of differentiating the concepts of fatigue and sleepiness.
- 2 May 2025
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 17 (1) , 37-50
Open AccessHypersomnolence and fatigue in patients in the acute period of ischemic stroke
INTRODUCTION. Fatigue after stroke has attracted research attention, but there is still insufficient evidence to estimate its prevalence and identify factors for its variability. As this condition has multiple implications for stroke survivors and the lives of their families, there is a need to find evidence regarding the causal relationship of fatigue with other post-stroke conditions.AIM. To evaluate the dependence of the degree of hypersomnolence and fatigue on the severity, volume, localisation of the lesion focus and subtype of ischemic stroke (IS) according to the TOAST classification and to study the influence of neurological deficit on the severity of fatigue in patients in the acute period of IS.MATERIALS AND METHODS. 80 patients in the acute period of IS were included in the study. During the examination, the subtype, basin and volume of the ischaemic focus were recorded. Fatigue was assessed using FIS and FSS scales, sleepiness was assessed using a sleep diary, ESS and KSS scales, and stroke severity was assessed using NIHSS, Rankin, Bartel, and Rivermead scales. Statistical data processing was performed using StatPlus Mac software package (USA). The significance level for statistical hypothesis testing was taken as p 0.05.RESULTS. Hypersomnolence was detected in 37 patients, predominantly with unspecified subtype of IS, without dependence on the volume of the focus and severity of IS. To a greater extent, drowsiness was demonstrated in patients with right-sided localisation of the ischemia focus. Fatigue was observed in 17 patients regardless of the subtype of IS, localisation and volume of IS. The level of fatigue was higher in patients with greater neurological deficit and less mobility. No association of fatigue with the presence or absence of hypersomnolence was found.CONCLUSION. The established correlation of hypersomnolence with the subtype of IS, affected hemisphere can serve as a reference point for predicting the outcomes of IS and developing individual patient treatment tactics. The revealed regularities, the discrepancy of data on the dependence of fatigue and sleepiness severity on the subtype of IS and localisation of the lesion focus allow us to assert the possibility of differentiating the concepts of fatigue and sleepiness.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (1)
Possibilities of predicting functional outcomes of ischemic stroke
Stroke occupies leading positions among the causes of disability and mortality. Prediction of functional outcomes of stroke has the potential to improve the efficiency of patient management, optimize strategies for providing medical care and rehabilitation measures, taking into account the rationalization of resource use. To date, there are no tools for rapid and comprehensive assessment of the prognosis for a physician to make a timely decision on choosing the most appropriate and promising management tactics for each patient, which requires systematization of known data on predicting stroke outcomes for the possibility of further optimization of this process. We have studied the existing possibilities for predicting the functional outcomes of ischemic stroke via PubMed, Scopus, eLIBRARY, Cyberleninka platforms, analyzed their advantages and disadvantages.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (1)
Possibilities of predicting functional outcomes of ischemic stroke
Stroke occupies leading positions among the causes of disability and mortality. Prediction of functional outcomes of stroke has the potential to improve the efficiency of patient management, optimize strategies for providing medical care and rehabilitation measures, taking into account the rationalization of resource use. To date, there are no tools for rapid and comprehensive assessment of the prognosis for a physician to make a timely decision on choosing the most appropriate and promising management tactics for each patient, which requires systematization of known data on predicting stroke outcomes for the possibility of further optimization of this process. We have studied the existing possibilities for predicting the functional outcomes of ischemic stroke via PubMed, Scopus, eLIBRARY, Cyberleninka platforms, analyzed their advantages and disadvantages.
- Open Access
- 9 March 2024
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 16 (1) , 84-97
Hypersomnolence in patients in the acute period of ischemic stroke and its impact on the development of fatigue and anxiety-depressive disorders
Гиперсомноленция у пациентов в остром периоде ишемического инсульта и ее влияние на развитие тревожно-депрессивных расстройств
- 9 March 2024
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 16 (1) , 84-97
Open AccessHypersomnolence in patients in the acute period of ischemic stroke and its impact on the development of fatigue and anxiety-depressive disorders
Гиперсомноленция у пациентов в остром периоде ишемического инсульта и ее влияние на развитие тревожно-депрессивных расстройств
- 8 September 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (8) , 37-46
Serum brain damage biomarkers as a diagnostic and prognostic tool in ischemic stroke
Objective. To study serum quantities of neuron specific enolase (NSE), glial fibrillary acidic protein (GFAP) and NR2-antibodies (NR2-ab) in various cerebrovascular pathology and assess their value as a panel used as a diagnostic and predictive tool for stroke. Material and methods. NSE, GFAP and NR2-ab serum levels were measured twice for 84 patients with ischemic stroke (IS) and 8 patients with hemorrhagic stroke (HI), once for 8 patients with transient ischemic attack (TIA), 26 patients with chronic brain ischemia (CBI), 27 healthy volunteers (HV). Results. NSE and GFAP levels were significantly higher in IS than in CBI and HV patients, and NR2-ab levels in IS were higher than in TIA and lower than in HV. In patients with more pronounced neurological deficiency and less favorable functional outcome by day 10—14 of IS, the levels of NSE, GFAP and NR2-ab were higher. Sensitivity and specificity of biomarker panel was higher than with their separate application. Conclusion. The NSE, GFAP and NR2-ab biomarkers have a diagnostic and predictive value for IS.
- 8 September 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (8) , 37-46
Serum brain damage biomarkers as a diagnostic and prognostic tool in ischemic stroke
Objective. To study serum quantities of neuron specific enolase (NSE), glial fibrillary acidic protein (GFAP) and NR2-antibodies (NR2-ab) in various cerebrovascular pathology and assess their value as a panel used as a diagnostic and predictive tool for stroke. Material and methods. NSE, GFAP and NR2-ab serum levels were measured twice for 84 patients with ischemic stroke (IS) and 8 patients with hemorrhagic stroke (HI), once for 8 patients with transient ischemic attack (TIA), 26 patients with chronic brain ischemia (CBI), 27 healthy volunteers (HV). Results. NSE and GFAP levels were significantly higher in IS than in CBI and HV patients, and NR2-ab levels in IS were higher than in TIA and lower than in HV. In patients with more pronounced neurological deficiency and less favorable functional outcome by day 10—14 of IS, the levels of NSE, GFAP and NR2-ab were higher. Sensitivity and specificity of biomarker panel was higher than with their separate application. Conclusion. The NSE, GFAP and NR2-ab biomarkers have a diagnostic and predictive value for IS.
- Open Access
- 25 May 2023
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 15 (2) , 166-175
The significance of sleep disorders in brain tumors (review of the literature)
Malignant brain tumors are particularly aggressive. Various kinds of sleep disturbances in patients with brain tumor lesions are a widespread problem. It is a known fact that there is a significant systemic pro-tumor impact of disturbed sleep in patients with malignant neoplasms of various localizations. In this connection, a review and systematization of current knowledge about sleep disturbances in malignant lesions was carried out, with a special emphasis on malignant brain neoplasms. In particular, the known mechanisms by which sleep disorders contribute to the progression of malignant tumors are reviewed. The second part of the paper, however, presents the theoretical basis for the reverse process. Namely, several pathophysiological mechanisms are described that make patients with malignant brain tumors more likely to experience sleep disturbances. There is reason to believe that normalization of sleep architectonics and circadian rhythms in patients with malignant brain tumors, firstly, has the potential to improve their quality of life and, secondly, gives hope by opening the possibility to actively inhibit the progression of this disease, especially when other treatment methods have been exhausted. That is why future research on this issue seems to be so necessary
- 25 May 2023
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 15 (2) , 166-175
Open AccessThe significance of sleep disorders in brain tumors (review of the literature)
Malignant brain tumors are particularly aggressive. Various kinds of sleep disturbances in patients with brain tumor lesions are a widespread problem. It is a known fact that there is a significant systemic pro-tumor impact of disturbed sleep in patients with malignant neoplasms of various localizations. In this connection, a review and systematization of current knowledge about sleep disturbances in malignant lesions was carried out, with a special emphasis on malignant brain neoplasms. In particular, the known mechanisms by which sleep disorders contribute to the progression of malignant tumors are reviewed. The second part of the paper, however, presents the theoretical basis for the reverse process. Namely, several pathophysiological mechanisms are described that make patients with malignant brain tumors more likely to experience sleep disturbances. There is reason to believe that normalization of sleep architectonics and circadian rhythms in patients with malignant brain tumors, firstly, has the potential to improve their quality of life and, secondly, gives hope by opening the possibility to actively inhibit the progression of this disease, especially when other treatment methods have been exhausted. That is why future research on this issue seems to be so necessary
- 27 February 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (2) , 144-150
Multiple system atrophy
The article presents a progressive neurodegenerative disease — multisystem atrophy, characterized by a combination of autonomic failure and various motor disorders, including parkinsonism and/or cerebellar ataxia; etiopathogenetic factors and variants of the clinical picture are described. We describe own clinical observation of a 59-old patient with cerebellar and bulbar syndromes, parkinsonism, pyramidal insufficiency, cognitive deficits, and autonomic dysfunction. The differential diagnosis included a whole range of neurodegenerative and hereditary diseases: Parkinson’s disease, vascular parkinsonism, progressive supranuclear palsy, spinocerebellar ataxia, FXTAS, mitochondrial encephalopathies. The moderate severity of parkinsonism and the significant predominance of cerebellar symptoms and autonomic dysfunction make this clinical case difficult to diagnose. However, based on the life and disease history, clinical picture and research methods, a diagnosis of multiple system atrophy, cerebellar type (cerebellar, autonomic, bulbar syndrome, parkinsonism, pyramidal insufficiency and moderate cognitive impairment) was established. Differential search in such patients is a difficult task and includes a whole range of neurodegenerative and hereditary diseases due to the similarity of individual clinical and neuroimaging features and, unfortunately, the limited availability of molecular genetic diagnostic methods. However, earlier diagnosis is necessary to focus in time on the development of a personalized approach to the management of each such patient, taking into account the rate of symptoms development and steady progression, in order to ensure the longest possible survival time with an acceptable level of quality of life.
- 27 February 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (2) , 144-150
Multiple system atrophy
The article presents a progressive neurodegenerative disease — multisystem atrophy, characterized by a combination of autonomic failure and various motor disorders, including parkinsonism and/or cerebellar ataxia; etiopathogenetic factors and variants of the clinical picture are described. We describe own clinical observation of a 59-old patient with cerebellar and bulbar syndromes, parkinsonism, pyramidal insufficiency, cognitive deficits, and autonomic dysfunction. The differential diagnosis included a whole range of neurodegenerative and hereditary diseases: Parkinson’s disease, vascular parkinsonism, progressive supranuclear palsy, spinocerebellar ataxia, FXTAS, mitochondrial encephalopathies. The moderate severity of parkinsonism and the significant predominance of cerebellar symptoms and autonomic dysfunction make this clinical case difficult to diagnose. However, based on the life and disease history, clinical picture and research methods, a diagnosis of multiple system atrophy, cerebellar type (cerebellar, autonomic, bulbar syndrome, parkinsonism, pyramidal insufficiency and moderate cognitive impairment) was established. Differential search in such patients is a difficult task and includes a whole range of neurodegenerative and hereditary diseases due to the similarity of individual clinical and neuroimaging features and, unfortunately, the limited availability of molecular genetic diagnostic methods. However, earlier diagnosis is necessary to focus in time on the development of a personalized approach to the management of each such patient, taking into account the rate of symptoms development and steady progression, in order to ensure the longest possible survival time with an acceptable level of quality of life.
- 1 January 2022
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 14 (4) , 133-143
SLEEP AND WAKE MEDIATORS AS LABORATORY BIOMARKERS OF POST-STROKE HYPERSOMNOLENCE (LITERATURE REVIEW)
В статье приводятся современные данные о роли нейротрансмиттерных систем в регуляции цикла «сон-бодрствование». Рассмотрены базовые принципы функционирования систем пробуждения, NREM- и REM-сна, дана характеристика ведущим медиаторам сна и бодрствования (мелатонин, орексины, ГАМК, глутамат, норадреналин, гистамин, дофамин, серотонин, ацетилхолин). Учитывая высокую актуальность профилактики осложнений инсульта и доказанную связь острого нарушения мозгового кровообращения с расстройствами спектра гиперсомноленции, приведены результаты анализа современных исследований по проблеме биомаркеров гиперсомноленции. Роль некоторых медиаторов, участвующих в регуляции процессов сна и бодрствования, остается не до конца изученной, что позволяет рассматривать их в качестве потенциальных биомаркеров гиперсомноленции. Возможными претендентами являются орексин-А, глутамат и ГАМК, также ацетилхолин. В данной статье приведен обзор имеющейся на данном этапе литературы о лабораторных маркерах гиперсомноленции и возможностях их оценки у пациентов с острым ишемическим...
- 1 January 2022
- Published by Federal State Budgetary Institution "National Medical Research Center named after. V.A. Almazov" Ministry of Health of the Russian Federation" in Russian Neurosurgical Journal named after Professor A. L. Polenov
- Vol. 14 (4) , 133-143
SLEEP AND WAKE MEDIATORS AS LABORATORY BIOMARKERS OF POST-STROKE HYPERSOMNOLENCE (LITERATURE REVIEW)
В статье приводятся современные данные о роли нейротрансмиттерных систем в регуляции цикла «сон-бодрствование». Рассмотрены базовые принципы функционирования систем пробуждения, NREM- и REM-сна, дана характеристика ведущим медиаторам сна и бодрствования (мелатонин, орексины, ГАМК, глутамат, норадреналин, гистамин, дофамин, серотонин, ацетилхолин). Учитывая высокую актуальность профилактики осложнений инсульта и доказанную связь острого нарушения мозгового кровообращения с расстройствами спектра гиперсомноленции, приведены результаты анализа современных исследований по проблеме биомаркеров гиперсомноленции. Роль некоторых медиаторов, участвующих в регуляции процессов сна и бодрствования, остается не до конца изученной, что позволяет рассматривать их в качестве потенциальных биомаркеров гиперсомноленции. Возможными претендентами являются орексин-А, глутамат и ГАМК, также ацетилхолин. В данной статье приведен обзор имеющейся на данном этапе литературы о лабораторных маркерах гиперсомноленции и возможностях их оценки у пациентов с острым ишемическим...